Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Lipigon Pharmaceuticals AB

9RP
Current price
0.0051 EUR +0.000000000018 EUR (+0.00%)
Last closed 0.23 SEK
ISIN SE0015382072
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 33 872 532 SEK
Yield for 12 month -64.39 %
1Y
3Y
5Y
10Y
15Y
9RP
21.11.2021 - 28.11.2021

Lipigon Pharmaceuticals AB (publ) develops drugs for lipid related diseases in Sweden. The company's product pipeline consists of Lipisense project for the treatment of severe hypertriglyceridemia disease; a gene therapy project for the treatment of the rare disease lipodystrophy; and RNA drug project for acute respiratory distress syndrome. Lipigon Pharmaceuticals AB (publ) has a collaboration agreement with HitGen Inc. for the development of small molecules for the treatment of dyslipidemia. The company was incorporated in 2010 and is based in Umeå, Sweden. Address: TvistevAegen 48 C, Umeå, Sweden, 90736

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

17.82 SEK

P/E ratio

Dividend Yield

Current Year

+16 325 343 SEK

Last Year

+388 059 SEK

Current Quarter

+8 925 356 SEK

Last Quarter

Current Year

-12 514 405 SEK

Last Year

+364 177 SEK

Current Quarter

-323 380 SEK

Last Quarter

-5 968 SEK

Key Figures 9RP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -21 744 036 SEK
Operating Margin TTM -5.6 %
PE Ratio
Return On Assets TTM -41.8 %
PEG Ratio
Return On Equity TTM -76.68 %
Wall Street Target Price 17.82 SEK
Revenue TTM 9 280 579 SEK
Book Value 0.17 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -44.1 %
Dividend Yield
Gross Profit TTM -31 497 453 SEK
Earnings per share -0.26 SEK
Diluted Eps TTM -0.26 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -217.17 %

Dividend Analytics 9RP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 9RP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 9RP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.5616
Price Sales TTM 3.9758
Enterprise Value EBITDA 0.0384
Price Book MRQ 1.3485

Financials 9RP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 9RP

For 52 weeks

0.22 SEK 0.82 SEK
50 Day MA 0.31 SEK
Shares Short Prior Month
200 Day MA 0.36 SEK
Short Ratio
Shares Short
Short Percent